These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30923288)

  • 1. Discontinuing Psychotropic Drugs from Participants in Randomized Controlled Trials: A Systematic Review.
    Cohen D; Recalt A
    Psychother Psychosom; 2019; 88(2):96-104. PubMed ID: 30923288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Withdrawal Confounding in Randomized Controlled Trials of Antipsychotic, Antidepressant, and Stimulant Drugs, 2000-2017.
    Récalt AM; Cohen D
    Psychother Psychosom; 2019; 88(2):105-113. PubMed ID: 30893683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications.
    Cosci F; Chouinard G
    Psychother Psychosom; 2020; 89(5):283-306. PubMed ID: 32259826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential adverse effects of discontinuing psychotropic drugs.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 Sep; 48(9):11-4. PubMed ID: 20795589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withdrawal effects confounding in clinical trials: another sign of a needed paradigm shift in psychopharmacology research.
    Cohen D; Recalt A
    Ther Adv Psychopharmacol; 2020; 10():2045125320964097. PubMed ID: 33224467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single Versus Multiple Daily Dosing Regimens of Psychotropic Drugs for Psychiatric Disorders: A Systematic Review and Meta-Analysis.
    Kikuchi Y; Shimomura Y; Suzuki T; Uchida H; Mimura M; Takeuchi H
    J Clin Psychiatry; 2021 Feb; 82(2):. PubMed ID: 33988935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis.
    Ford AC; Luthra P; Tack J; Boeckxstaens GE; Moayyedi P; Talley NJ
    Gut; 2017 Mar; 66(3):411-420. PubMed ID: 26567029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings.
    Denis C; Fatséas M; Lavie E; Auriacombe M
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005194. PubMed ID: 16856084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential adverse effects of discontinuing psychotropic drugs. Part 3: Antipsychotic, dopaminergic, and mood-stabilizing drugs.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 Aug; 48(8):11-4. PubMed ID: 20669865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review.
    Fava GA; Benasi G; Lucente M; Offidani E; Cosci F; Guidi J
    Psychother Psychosom; 2018; 87(4):195-203. PubMed ID: 30016772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consequences of a benzodiazepine discontinuation programme in family practice on psychotropic medication prescription to the participants.
    Gorgels WJ; Oude Voshaar RC; Mol AJ; van de Lisdonk EH; Mulder J; van den Hoogen H; van Balkom AJ; Breteler MH; Zitman FG
    Fam Pract; 2007 Oct; 24(5):504-10. PubMed ID: 17644828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Open-Label Discontinuation Trial of Long-Term, Off-Label Antipsychotic Medication in People With Intellectual Disability: Determinants of Success and Failure.
    de Kuijper GM; Hoekstra PJ
    J Clin Pharmacol; 2018 Nov; 58(11):1418-1426. PubMed ID: 29920689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abrupt discontinuation of psychotropic drugs following confirmation of pregnancy: a risky practice.
    Einarson A
    J Obstet Gynaecol Can; 2005 Nov; 27(11):1019-22. PubMed ID: 16529668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotropic discontinuation symptoms: a case of withdrawal neuroleptic malignant syndrome.
    Stonecipher A; Galang R; Black J
    Gen Hosp Psychiatry; 2006; 28(6):541-3. PubMed ID: 17088172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.
    Sink KM; Holden KF; Yaffe K
    JAMA; 2005 Feb; 293(5):596-608. PubMed ID: 15687315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
    Kishi T; Matsuda Y; Iwata N; Correll CU
    J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzodiazepines for schizophrenia.
    Volz A; Khorsand V; Gillies D; Leucht S
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006391. PubMed ID: 17253592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Melatonin on Benzodiazepine Discontinuation and Sleep Quality in Adults Attempting to Discontinue Benzodiazepines: A Systematic Review and Meta-Analysis.
    Wright A; Diebold J; Otal J; Stoneman C; Wong J; Wallace C; Duffett M
    Drugs Aging; 2015 Dec; 32(12):1009-18. PubMed ID: 26547856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychotropic drug withdrawal and the dexamethasone suppression test.
    Kraus RP; Hux M; Grof P
    Am J Psychiatry; 1987 Jan; 144(1):82-5. PubMed ID: 3799844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.